Patel Mahesh V.

Chief Executive Officer, DirectorLipocine Inc. (LPCN) · full profile →Form 4 · filed Dec 17, 2020
Net Selling
Open-Market Buys
$0
Open-Market Sells
$20K
Net Open-Market Flow
-$20K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2020Sell(S)15K$1.35$20K1.2M
Dec 16, 2020Option exercise(M)45K$01.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2020Option exercise(M)45K$045K
Dec 15, 2020Grant(A)375K$1.37$514K375K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001638599-20-000977) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about LPCN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001638599-20-000977"
Ask your agent
Use Arkolith to summarize insider buying and selling at Lipocine Inc.
over the last 90 days and cite the filings.